Skandinaviska Enskilda Banken (SEB)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22,200
| Closed | -$1.3M | – | 982 |
|
|
2023
Q4 | $1.3M | Buy |
22,200
+9,061
| +69% | +$532K | 0.01% | 655 |
|
|
2023
Q3 | $572K | Sell |
13,139
-35,214
| -73% | -$1.53M | ﹤0.01% | 748 |
|
|
2023
Q2 | $1.75M | Sell |
48,353
-46,559
| -49% | -$1.68M | 0.01% | 584 |
|
|
2023
Q1 | $3.53M | Sell |
94,912
-583
| -0.6% | -$21.7K | 0.02% | 426 |
|
|
2022
Q4 | $4.33M | Sell |
95,495
-40
| -0% | -$1.81K | 0.03% | 376 |
|
|
2022
Q3 | $6.67M | Buy |
95,535
+40,693
| +74% | +$2.84M | 0.05% | 304 |
|
|
2022
Q2 | $3.68M | Hold |
54,842
| – | – | 0.03% | 424 |
|
|
2022
Q1 | $4.51M | Sell |
54,842
-27
| -0% | -$2.22K | 0.03% | 428 |
|
|
2021
Q4 | $8.13M | Buy |
54,869
+334
| +0.6% | +$49.5K | 0.04% | 329 |
|
|
2021
Q3 | $9.65M | Sell |
54,535
-13,098
| -19% | -$2.32M | 0.05% | 294 |
|
|
2021
Q2 | $10.9M | Buy |
67,633
+58,774
| +663% | +$9.49M | 0.07% | 263 |
|
|
2021
Q1 | $1.52M | Buy |
+8,859
| New | +$1.52M | 0.01% | 734 |
|